Free shipping on all orders over $ 500

Pegcetacoplan

Cat. No. M31313

All AbMole products are for research use only, cannot be used for human consumption.

Pegcetacoplan Structure
Synonym:

APL-2

Size Price Availability Quantity
1mg USD 155 In stock
5mg USD 400 In stock
10mg USD 580 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Pegcetacoplan is a polyethylene glycolated peptide and an inhibitor of complement protein C3 that inhibits intravascular and extravascular hemolysis.

Protocol (for reference only)
Cell Experiment
Cell lines HMEC-1 cells
Preparation method HMEC-1 cells were activated with 10 µM ADP, then incubated with either pooled NHS or primary aHUS serum (aHUS3–5, diluted 1:2 in HBSS + 0.5% BSA) in the presence or absence of CPV-104 (500 µg/ml), sd-FH (500 µg/ml) or pegcetacoplan (1 mg/ml) for 4 h at 37°C.
Concentrations 1 mg/mL
Incubation time 4 h
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
CAS Number 2019171-69-6
Storage -20°C, protect from light, dry, sealed
References

[1] Raymond S M Wong. Ther Adv Hematol. Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuria

[2] David S Liao, et al. Immunotherapy. Pegcetacoplan treatment for geographic atrophy due to age-related macular degeneration: a plain language summary of the FILLY study

[3] Sheridan M Hoy. Drugs. Pegcetacoplan: First Approval

[4] Peter Hillmen, et al. N Engl J Med. Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

[5] David S Liao, et al. Ophthalmology. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial

Related Complement System Products
Eculizumab

Eculizumab is a first-in-class recombinant humanized monoclonal antibody targeting complement protein C5. C5, which can only recognize humans, cannot bind to C5 of other species.

SB290157 trifluoroacetate salt

SB290157 is a selective antagonist of complement anaphylatoxin C3a receptor, a 74 amino acid proinflammatory peptide that is a potent chemotaxin for eosinophils, macrophages and mast cells.

JPE-1375

JPE-1375 is a complement C5a receptor 1 (C5aR1) antagonist. JPE-1375 effectively inhibits polymorphonuclear leukocyte mobilization (EC50=6.9 µM) and reduces TNF levels (EC50=4.5 µM) in mice.

Compstatin

Compstatinis is a 13-residue cyclic peptide, binds to complement component C3 and inhibits complement activation with IC50 of 12 μM. Compstatin exhibits exclusive specificity for primate C3s and does not bind either to C3s from lower mammalian species or to two structural homologs of C3, human C4 and C5.

Avacopan

Avacopan (CCX168) is a first-in-class, potent, selective and orally available complement 5a receptor (C5aR1 or CD88) antagonist with an IC50 of 0.1 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Pegcetacoplan, APL-2 supplier, Complement System, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.